Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PHAT Phathom Pharmaceuticals

Market Closed 11-06 16:00:00 EST

5.25

+0.17

+3.35%

盘后5.25

+0.000.00%

19:44 EST

High5.31	Low5.04	Vol1.77M
Open5.26	D1 Closing5.08	Amplitude5.22%
Mkt Cap424.73M	Tradable Cap345.19M	Total Shares80.90M
T/O9.15M	T/O Rate2.69%	Tradable Shares65.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":5.25,"timestamp":1793998800000,"preClose":5.08,"halted":0,"volume":1770849,"hourTrading":{"tag":"盘后","latestPrice":5.25,"preClose":5.25,"latestTime":"19:44 EST","volume":18446,"amount":96841.5,"timestamp":1794012270027,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03346456692913384,"floatShares":65750400,"shares":80900900,"eps":-1.022909,"marketStatus":"Market Closed","change":0.17,"latestTime":"11-06 16:00:00 EST","open":5.26,"high":5.305,"low":5.04,"amount":9150794.915238,"amplitude":0.052165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.022909,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":5.08,"preHourTrading":{"tag":"盘前","latestPrice":5.26,"preClose":5.08,"latestTime":"09:29 EST","volume":601,"amount":3161.1400403999996,"timestamp":1793975399999,"change":0.18,"changeRate":0.035433,"amplitude":0.023622},"postHourTrading":{"tag":"盘后","latestPrice":5.25,"preClose":5.25,"latestTime":"19:44 EST","volume":18446,"amount":96841.5,"timestamp":1794012270027,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9163604627421347,"impliedVol":2.3974,"impliedVolPercentile":0.9363},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2680005117","title":"Phathom Pharmaceuticals to Participate in Three Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2680005117","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680005117?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:05","pubTimestamp":1793797544,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals to Participate in Three Investor ConferencesPhathom Pharmaceuticals management will attend three investor conferences in November 2026, with fireside chats and one-on-one meeti","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDLc2p5kQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","BK4112","PHAT","BK4585","BK4588","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014039.USD","BCDF","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BKPKM429.USD","BK4007","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680729215","title":"Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May NOW Pay as Little as $0 for Voquezna® (Vonoprazan) Tablets Exclusively at Blinkrx","url":"https://stock-news.laohu8.com/highlight/detail?id=2680729215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680729215?lang=en_us&edition=fundamental","pubTime":"2026-11-03 21:00","pubTimestamp":1793710805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nTUA5NMVFY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679459297","title":"Phathom Pharmaceuticals (PHAT) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2679459297","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679459297?lang=en_us&edition=fundamental","pubTime":"2026-10-30 18:37","pubTimestamp":1793356676,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on Phathom Pharmaceuticals today and set a price target of $26.00. Caufield covers...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/phathom-pharmaceuticals-phat-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/phathom-pharmaceuticals-phat-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679948972","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Alnylam Pharma (ALNY) and Illumina (ILMN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679948972","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679948972?lang=en_us&edition=fundamental","pubTime":"2026-10-30 17:50","pubTimestamp":1793353846,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phathom Pharmaceuticals (PHAT), Alnylam Pharma (ALNY) and Illumin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-alnylam-pharma-alny-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-alnylam-pharma-alny-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4139","BK4581","XBI","GNMX","LU0889565916.HKD","HCSG","BK4137","BK4535","GNOM","LU0882574055.USD","BK4534","PBE","LU0128526141.USD","LU0320765992.SGD","BK4121","BK4588","ALNY","LABU","BK4585","LU0109394709.USD","LU0114720955.EUR","PHAT","XLV","BK4007","BK4548","ILMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679234401","title":"Aptar Q3 Profit Falls on Russia Deconsolidation Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2679234401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679234401?lang=en_us&edition=fundamental","pubTime":"2026-10-30 05:11","pubTimestamp":1793308289,"startTime":"0","endTime":"0","summary":"Aptar Q3 profit falls on Russia deconsolidation chargeOverviewDrug delivery and dispensing firm's Q3 sales rose 6%, beating analyst expectationsAdjusted EPS for Q3 was $1.52, beating analyst expectati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nL2N46F1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4126","LU0566484027.USD","HELX","IE0009354923.USD","LGND","IE00B64QTZ34.USD","BK4007","PHAT","IE00BLDYK493.USD","BK4139","LU1559883803.SGD","ATR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679280746","title":"Phathom Pharmaceuticals, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2679280746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679280746?lang=en_us&edition=fundamental","pubTime":"2026-10-30 02:19","pubTimestamp":1793297967,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings SummaryPhathom Pharmaceuticals, Inc.PHAT.OQreported a quarterly adjusted loss of 16 cents per share for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nL5N46F399:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679406789","title":"Phathom Maintains 2026 Net Revenue Forecast of $310 Million-$325 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2679406789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679406789?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:39","pubTimestamp":1793273988,"startTime":"0","endTime":"0","summary":"Phathom Maintains 2026 Net Revenue Forecast of $310 Million-$325 MillionPhathom Pharmaceuticals maintained its 2026 net revenue guidance of $310 million to $325 million.Operating expense guidance rema","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL3hXkXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679082904","title":"Phathom Pharmaceuticals Q3 Net Income USD -13.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2679082904","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679082904?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:01","pubTimestamp":1793271662,"startTime":"0","endTime":"0","summary":"BRIEF-Phathom Pharmaceuticals Q3 Net Income USD -13.9 MillionOct 29 (Reuters) - Phathom Pharmaceuticals Q3 revenue USD 84.7 million vs. IBES estimate USD 84.9 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nPLX5551S9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679408796","title":"Phathom Pharmaceuticals Q3 Adj. EPS $0.04 Beats $0.02 Estimate, Sales $84.722M Miss $85.096M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2679408796","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679408796?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:00","pubTimestamp":1793271657,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 100 percent. This is a 126.67 percent increase over losses of $(0.15) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/10/62688013/phathom-pharmaceuticals-q3-adj-eps-0-04-beats-0-02-estimate-sales-84-722m-miss-85-096m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403226","title":"Phathom Pharmaceuticals - Reaffirmed Full-Year 2026 Financial Guidancec","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679403226?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:00","pubTimestamp":1793271603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nPLX5551S9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678103036","title":"Did Phathom Pharmaceuticals’ 62% Drop Catch You Out? What Investors Missed","url":"https://stock-news.laohu8.com/highlight/detail?id=2678103036","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678103036?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:22","pubTimestamp":1793107328,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals spent 2026 releasing upbeat headlines, from a sharply smaller Q2 loss to fresh cost effectiveness data for VOQUEZNA at the ACG meeting. For Phathom Pharmaceuticals shareholders, the loss from the start of the year was 62.2%, including dividends. If you had put money in on 1 January, that gap between improving financial metrics and a deep capital drawdown is hard to ignore. Did the business story really change, or did expectations change?\nNarratives are how investors...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/did-phathom-pharmaceuticals-62-drop-catch-you-out-what-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/did-phathom-pharmaceuticals-62-drop-catch-you-out-what-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK4007","ISBC","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678766166","title":"Phathom Pharmaceuticals provides update on FDA litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2678766166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678766166?lang=en_us&edition=fundamental","pubTime":"2026-10-26 17:30","pubTimestamp":1793007037,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (PHAT) announced the FDA’s establishment of a public docket to solicit comment on legal and regulatory questions regarding ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-provides-update-on-fda-litigation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-provides-update-on-fda-litigation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678150153","title":"Phathom Seeks to Intervene in Lawsuit Challenging Voquezna Exclusivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2678150153","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678150153?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:00","pubTimestamp":1793001643,"startTime":"0","endTime":"0","summary":"Phathom Seeks to Intervene in Lawsuit Challenging Voquezna ExclusivityPhathom Pharmaceuticals moved to intervene in BDR Pharmaceuticals' lawsuit against the FDA to defend VOQUEZNA's regulatory exclusi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDL7w4yBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B64PRP62.GBP","BK4585","IE00BQXX3F31.USD","IE00BKPKM429.USD","BK4588","BCDF","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","PHAT","IE00BN0W2W23.USD","BK4112","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3C00.GBP","BK4007","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678150647","title":"Phathom Pharmaceuticals Provides Update on FDA Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2678150647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678150647?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:00","pubTimestamp":1793001600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nTUA5MNVPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678150135","title":"Phathom Pharmaceuticals - Deadline for Comments to FDA Public Docket is November 23, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2678150135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678150135?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:00","pubTimestamp":1793001600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nTUA5MNVPL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677971839","title":"Cantor sees low odds of suit leading FDA to reverse on Phathom exclusivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2677971839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677971839?lang=en_us&edition=fundamental","pubTime":"2026-10-24 01:10","pubTimestamp":1792775413,"startTime":"0","endTime":"0","summary":"After Phathom Pharmaceuticals (PHAT) announced that BDR Pharmaceuticals filed a suit against the FDA, challenging the agency’s refusal to receive a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cantor-sees-low-odds-of-suit-leading-fda-to-reverse-on-phathom-exclusivity-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cantor-sees-low-odds-of-suit-leading-fda-to-reverse-on-phathom-exclusivity-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","PHAT","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677403919","title":"Phathom Pharmaceuticals Faces Legal Challenge Over VOQUEZNA Exclusivity","url":"https://stock-news.laohu8.com/highlight/detail?id=2677403919","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677403919?lang=en_us&edition=fundamental","pubTime":"2026-10-23 17:39","pubTimestamp":1792748362,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals  said Friday that BDR Pharmaceuticals International has sued the US Food and Drug Administration, or FDA, challenging its alleged refusal to accept a generic drug application referencing Phathom's VOQUEZNA.BDR alleges the FDA improperly applied the GAIN Act to extend the drug's new chemical entity exclusivity, it said.Phathom said the FDA correctly granted its citizen petition in June 2025, recognizing exclusivity for VOQUEZNA tablets through May 3, 2032.The company said it is evaluating the lawsuit and intends to take appropriate action to protect its exclusivity rights.Phathom Pharmaceuticals was down 2.9% in Friday premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","PHAT","BK4588","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677492019","title":"BDR Sues FDA over Exclusivity Extension for Phathom's Voquezna","url":"https://stock-news.laohu8.com/highlight/detail?id=2677492019","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677492019?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:00","pubTimestamp":1792742442,"startTime":"0","endTime":"0","summary":"BDR sues FDA over exclusivity extension for Phathom's VoqueznaBDR Pharmaceuticals sued the FDA in federal court in Washington, D.C., challenging exclusivity protections for Phathom Pharmaceuticals' VO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDLp18D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","BCDF","LU2210150020.SGD","IE00BN0W2W23.USD","BK4585","IE00BQXX3F31.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BK4588","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014039.USD","BK4007","IE00BN0W2T93.GBP","PHAT","LU0314104364.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677949795","title":"Phathom Pharmaceuticals Inc: Has Filed Suit Against FDA and Related Federal Defendants in United States District Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2677949795","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677949795?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:00","pubTimestamp":1792742400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA4QVMCL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677694927","title":"Phathom Pharmaceuticals Provides Update on Litigation Filed by Bdr Pharmaceuticals Against FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2677694927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677694927?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:00","pubTimestamp":1792742400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA4QVMCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.0854},{"period":"1month","weight":-0.2291},{"period":"3month","weight":-0.386},{"period":"6month","weight":-0.5683},{"period":"1year","weight":-0.5974},{"period":"ytd","weight":-0.6835}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119249},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046876},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.041373},{"month":6,"riseRate":0.714286,"avgChangeRate":0.230291},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.006164},{"month":8,"riseRate":0.714286,"avgChangeRate":0.143553},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.036982},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.064861},{"month":11,"riseRate":0.375,"avgChangeRate":-0.098514},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}